Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.63B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.14B |
| 3 |
Oracle
ORCL
|
+$1.04B |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$859M |
| 5 |
S&P Global
SPGI
|
+$832M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$1.17B |
| 2 |
Trade Desk
TTD
|
+$1B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$895M |
| 4 |
Constellation Brands
STZ
|
+$861M |
| 5 |
Carvana
CVNA
|
+$851M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.59% |
| 2 | Technology | 20.43% |
| 3 | Financials | 12.09% |
| 4 | Consumer Discretionary | 8.79% |
| 5 | Healthcare | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
126
Morgan Stanley Pathway Large Cap Equity ETF
MSLC
$4.03B
| $2.03B | 0.15% |
43,845,973
+1,641,507
| +4% | +$79.4M |
2024 Q4
1 quarter
|
|
127
State Street Technology Select Sector SPDR ETF
XLK
$121B
| $2.03B | 0.15% |
19,644,558
-81,744
| -0.4% | -$9.27M |
2013 Q2
47 quarters
|
|
128
Deere & Co
DE
$172B
| $2.01B | 0.14% |
4,292,346
-94,164
| -2% | -$44.1M |
2013 Q2
47 quarters
|
|
129
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$50.9B
| $1.99B | 0.14% |
21,644,765
+2,246,904
| +12% | +$206M |
2013 Q2
47 quarters
|
|
130
Becton Dickinson
BDX
$51.9B
| $1.97B | 0.14% |
8,589,897
-1,647,488
| -16% | -$382M |
2013 Q2
47 quarters
|
|
131
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45B
| $1.96B | 0.14% |
4,675,578
+696,065
| +17% | +$301M |
2013 Q2
47 quarters
|
|
132
TransDigm Group
TDG
$63B
| $1.96B | 0.14% |
1,416,974
-18,883
| -1% | -$25.2M |
2013 Q2
47 quarters
|
|
133
iShares Core S&P Small-Cap ETF
IJR
$102B
| $1.96B | 0.14% |
18,703,932
-452,118
| -2% | -$51M |
2013 Q2
47 quarters
|
|
134
Bristol-Myers Squibb
BMY
$124B
| $1.95B | 0.14% |
31,938,714
+1,598,939
| +5% | +$93.2M |
2013 Q2
47 quarters
|
|
135
Chubb
CB
$137B
| $1.94B | 0.14% |
6,422,791
+52,290
| +0.8% | +$14.5M |
2013 Q2
47 quarters
|
|
136
Analog Devices
ADI
$193B
| $1.92B | 0.14% |
9,544,873
+287,597
| +3% | +$62.2M |
2013 Q2
47 quarters
|
|
137
Boston Scientific
BSX
$63.9B
| $1.92B | 0.14% |
19,036,916
-1,443,859
| -7% | -$145M |
2013 Q2
47 quarters
|
|
138
Boeing
BA
$149B
| $1.84B | 0.13% |
10,770,757
+1,443,471
| +15% | +$250M |
2013 Q2
47 quarters
|
|
139
ConocoPhillips
COP
$175B
| $1.81B | 0.13% |
17,266,149
-3,587,400
| -17% | -$358M |
2013 Q2
47 quarters
|
|
140
Comcast
CMCSA
$78.1B
| $1.81B | 0.13% |
48,991,900
-6,389,448
| -12% | -$231M |
2013 Q2
47 quarters
|
|
141
American Tower
AMT
$86.3B
| $1.8B | 0.13% |
8,287,593
+481,104
| +6% | +$94.4M |
2013 Q2
47 quarters
|
|
142
General Dynamics
GD
$92.7B
| $1.8B | 0.13% |
6,587,411
+1,226,836
| +23% | +$319M |
2013 Q2
47 quarters
|
|
143
Colgate-Palmolive
CL
$74.2B
| $1.78B | 0.13% |
18,990,012
+441,010
| +2% | +$39.5M |
2013 Q2
47 quarters
|
|
144
State Street Health Care Select Sector SPDR ETF
XLV
$45.7B
| $1.77B | 0.13% |
12,120,071
+1,242,217
| +11% | +$180M |
2013 Q2
47 quarters
|
|
145
Ecolab
ECL
$80.5B
| $1.77B | 0.13% |
6,970,061
+1,083,941
| +18% | +$273M |
2013 Q2
47 quarters
|
|
146
Medtronic
MDT
$121B
| $1.75B | 0.12% |
19,427,894
+489,528
| +3% | +$43.8M |
2013 Q2
47 quarters
|
|
147
iShares Core S&P US Growth ETF
IUSG
$33.3B
| $1.73B | 0.12% |
13,586,821
+569,601
| +4% | +$78.8M |
2013 Q2
47 quarters
|
|
|
148
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.8B
| $1.72B | 0.12% |
21,778,044
+10,824,185
| +99% | +$859M |
2013 Q2
47 quarters
|
|
149
iShares 20+ Year Treasury Bond ETF
TLT
$49.7B
| $1.72B | 0.12% |
18,861,288
-1,797,755
| -9% | -$160M |
2013 Q2
47 quarters
|
|
150
Waste Management
WM
$89.8B
| $1.71B | 0.12% |
7,368,470
+9,551
| +0.1% | +$2.12M |
2013 Q2
47 quarters
|
|
Similar funds
Morgan Stanley's Q1 2025 Portfolio in Review
As of Q1 2025, Morgan Stanley held 8,359 positions worth $1.4T, down 2% from $1.43T the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Morgan Stanley's Q1 2025 filing shows 407 new, 3,433 increased, 3,304 reduced and 268 closed positions. Its largest new stake was Sandisk: 1,632,771 shares worth $77.7M. The largest sale was Intel, an estimated $1.17B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q1 2025 buy was Sandisk: 1,632,771 shares worth $77.7M.
- Morgan Stanley added most to Invesco QQQ Trust in Q1 2025, an estimated $1.63B increase.
- Morgan Stanley's biggest Q1 2025 reduction was Intel, cutting an estimated $1.17B.
- Morgan Stanley fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $110M.
- Morgan Stanley's ten largest holdings make up 20% of its $1.4T portfolio in Q1 2025.
- Morgan Stanley opened 407 new positions and closed 268 in Q1 2025.
- Morgan Stanley's portfolio value fell 2% quarter-over-quarter to $1.4T.
Based on Morgan Stanley's 13F filing for Q1 2025, filed 15 May 2025.